Public company
REPLIGEN CORP
RGENCIK 0000730272
Price$173.49
1 year+19.0%
Disclosed transactions9
Buys / sells0 / 2
Max Insider Score18
Connections with evidence4
RGEN · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Douglass Brian RobbCHIEF PRODUCT OFFICER | RGENREPLIGEN CORP Grant or award | A | — 700 sh | Oct 8, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
- ← Insider ofevidenceDouglass Brian RobbCHIEF PRODUCT OFFICER · Oct 8, 2026
- ← Insider ofevidenceGarland Jason KCFO · Sep 28, 2026
- ← Insider ofevidenceLoeillot OlivierDirector, Chief Executive Officer · Sep 25, 2026